Literature DB >> 21508008

Clinical epidemiology of carbapenem-intermediate or -resistant Enterobacteriaceae.

Nimish Patel1, Susan Harrington, Amanda Dihmess, Benjamin Woo, Rasha Masoud, Pearl Martis, Mallory Fiorenza, Eileen Graffunder, Ann Evans, Louise-Anne McNutt, Thomas P Lodise.   

Abstract

OBJECTIVES: Despite the increasing incidence of carbapenem-intermediate or -resistant Enterobacteriaceae (CIRE), risk factors associated with CIRE infections have not been well defined. This study characterizes factors associated with CIRE among two different source populations.
METHODS: A case-control study was performed at a tertiary care medical centre between January 2005 and December 2009. Cases were adults with a culture-confirmed Enterobacteriaceae infection with reduced susceptibility to meropenem or ertapenem. The CIRE cases were matched 1:1 to patients from two different control series: (i) those with carbapenem-susceptible Enterobacteriaceae (CSE) infections; and (ii) inpatients residing on the same ward within 30 days of CIRE culture date. Logistic regression was used to identify variables independently associated with CIRE among each source population. Restricted multivariate analyses were performed to determine if covariates predictive of CIRE varied by infecting organism or presence of the bla(KPC) gene.
RESULTS: There were 102 cases of CIRE during the study period. The only covariate independently associated with CIRE in all multivariate analyses was the cumulative number of prior antibiotic exposures. Compared with CSE controls, the odds ratios (95% confidence interval) were 1.43 (1.19-1.72), 2.05 (1.70-2.47) and 2.93 (2.43-3.53) for 1, 2 and ≥ 3 antibiotic exposures, respectively. The strength of this association was comparable for the hospitalized control group and analyses stratified by organism and presence of the bla(KPC) gene.
CONCLUSIONS: A patient's cumulative antibiotic exposure history is likely to be more important than any one specific exposure when determining the likelihood of developing a CIRE infection.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21508008     DOI: 10.1093/jac/dkr156

Source DB:  PubMed          Journal:  J Antimicrob Chemother        ISSN: 0305-7453            Impact factor:   5.790


  23 in total

1.  Correlations of antibiotic use and carbapenem resistance in enterobacteriaceae.

Authors:  Milena McLaughlin; M Renee Advincula; Michael Malczynski; Chao Qi; Maureen Bolon; Marc H Scheetz
Journal:  Antimicrob Agents Chemother       Date:  2013-07-08       Impact factor: 5.191

Review 2.  Leveraging antimicrobial stewardship into improving rates of carbapenem-resistant Enterobacteriaceae.

Authors:  Darren Wong; Brad Spellberg
Journal:  Virulence       Date:  2016-05-17       Impact factor: 5.882

3.  Epidemiology of Carbapenem-Resistant Enterobacteriaceae Infections: Report from the China CRE Network.

Authors:  Yawei Zhang; Qi Wang; Yuyao Yin; Hongbin Chen; Longyang Jin; Bing Gu; Liangyi Xie; Chunxia Yang; Xiaobo Ma; Huayin Li; Wei Li; Xiaoqian Zhang; Kang Liao; Sijin Man; Shifu Wang; Hainan Wen; Binbin Li; Zhusheng Guo; Jinjing Tian; Fengyan Pei; Li Liu; Lijun Zhang; Cuimei Zou; Tongping Hu; Jun Cai; Hong Yang; Jiaming Huang; Xianghong Jia; Wenhui Huang; Bin Cao; Hui Wang
Journal:  Antimicrob Agents Chemother       Date:  2018-01-25       Impact factor: 5.191

Review 4.  Carbapenemases in Klebsiella pneumoniae and other Enterobacteriaceae: an evolving crisis of global dimensions.

Authors:  L S Tzouvelekis; A Markogiannakis; M Psichogiou; P T Tassios; G L Daikos
Journal:  Clin Microbiol Rev       Date:  2012-10       Impact factor: 26.132

5.  Predictive models for identification of hospitalized patients harboring KPC-producing Klebsiella pneumoniae.

Authors:  Mario Tumbarello; Enrico Maria Trecarichi; Fabio Tumietto; Valerio Del Bono; Francesco Giuseppe De Rosa; Matteo Bassetti; Angela Raffaella Losito; Sara Tedeschi; Carolina Saffioti; Silvia Corcione; Maddalena Giannella; Francesca Raffaelli; Nicole Pagani; Michele Bartoletti; Teresa Spanu; Anna Marchese; Roberto Cauda; Claudio Viscoli; Pierluigi Viale
Journal:  Antimicrob Agents Chemother       Date:  2014-04-14       Impact factor: 5.191

6.  2013 WSES guidelines for management of intra-abdominal infections.

Authors:  Massimo Sartelli; Pierluigi Viale; Fausto Catena; Luca Ansaloni; Ernest Moore; Mark Malangoni; Frederick A Moore; George Velmahos; Raul Coimbra; Rao Ivatury; Andrew Peitzman; Kaoru Koike; Ari Leppaniemi; Walter Biffl; Clay Cothren Burlew; Zsolt J Balogh; Ken Boffard; Cino Bendinelli; Sanjay Gupta; Yoram Kluger; Ferdinando Agresta; Salomone Di Saverio; Imtiaz Wani; Alex Escalona; Carlos Ordonez; Gustavo P Fraga; Gerson Alves Pereira Junior; Miklosh Bala; Yunfeng Cui; Sanjay Marwah; Boris Sakakushev; Victor Kong; Noel Naidoo; Adamu Ahmed; Ashraf Abbas; Gianluca Guercioni; Nereo Vettoretto; Rafael Díaz-Nieto; Ihor Gerych; Cristian Tranà; Mario Paulo Faro; Kuo-Ching Yuan; Kenneth Yuh Yen Kok; Alain Chichom Mefire; Jae Gil Lee; Suk-Kyung Hong; Wagih Ghnnam; Boonying Siribumrungwong; Norio Sato; Kiyoshi Murata; Takayuki Irahara; Federico Coccolini; Helmut A Segovia Lohse; Alfredo Verni; Tomohisa Shoko
Journal:  World J Emerg Surg       Date:  2013-01-08       Impact factor: 5.469

7.  Risk factors, molecular epidemiology and outcomes of ertapenem-resistant, carbapenem-susceptible Enterobacteriaceae: a case-case-control study.

Authors:  Jocelyn Teo; Yiying Cai; Sarah Tang; Winnie Lee; Thean Yen Tan; Thuan Tong Tan; Andrea Lay-Hoon Kwa
Journal:  PLoS One       Date:  2012-03-26       Impact factor: 3.240

8.  Impact of cascade reporting of antimicrobial susceptibility on fluoroquinolone and meropenem consumption at a Veterans' Affairs medical center.

Authors:  Nicole C Vissichelli; Christine M Orndahl; Jane A Cecil; Emily M Hill; Matthew M Hitchcock; Roy T Sabo; Michael P Stevens; Dan Tassone; Leroy B Vaughan; J Daniel Markley
Journal:  Infect Control Hosp Epidemiol       Date:  2021-04-06       Impact factor: 6.520

9.  Risk factors for acquisition of carbapenem resistant Enterobacteriaceae in an acute tertiary care hospital in Singapore.

Authors:  Moi Lin Ling; Yong Ming Tee; Soong Geck Tan; Ismawati M Amin; Kue Bien How; Kwee Yuen Tan; Lai Chee Lee
Journal:  Antimicrob Resist Infect Control       Date:  2015-06-23       Impact factor: 4.887

10.  Transmission dynamics of carbapenemase-producing Klebsiella pneumoniae and anticipated impact of infection control strategies in a surgical unit.

Authors:  Vana Sypsa; Mina Psichogiou; Georgia-Aikaterina Bouzala; Linos Hadjihannas; Angelos Hatzakis; Georgios L Daikos
Journal:  PLoS One       Date:  2012-07-31       Impact factor: 3.240

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.